Related Experiment Video
Updated: Oct 7, 2025

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
The detection of keratoconus using novel metrics derived by anterior segment optical coherence tomography
Isa S K Mohammed1, Sang Tran1, Luis A Toledo-Espiett1
1Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, 419 W Redwood Street, Suite 470, Baltimore, MD, 21201, USA.
Purpose:
To determine through a feasibility study whether anterior and posterior corneal arc length and cross-sectional area measured using anterior segment ocular coherence tomography (AS-OCT) can distinguish between healthy and keratoconic corneas.
Methods:
Patients diagnosed with keratoconus along with healthy controls underwent AS-OCT. ImageJ was used to determine the central 6 mm anterior and posterior corneal arc lengths and cross-sectional areas. Each length and area was then divided into 1-mm segment and relative differences compared.
Results:
Twenty-five eyes from 15 patients with keratoconus, along with 25 eyes from 14 healthy controls were enrolled. There was a statistically significant difference in anterior and posterior corneal arc lengths as well as corneal cross-sectional area (p = 0.006, p = 0.005, p = 0.01, respectively). When selecting for the less advanced keratoconus eye, it was noted that posterior corneal arc length was longer in the paracentral temporal segment (1003 vs. 1010 µm, p = 0.04) and that greater change in corneal cross-sectional areas occurred between adjacent segments in less advanced keratoconus eyes.
Conclusion:
AS-OCT is capable of reliably measuring corneal arc lengths in patients with keratoconus and healthy patients. Both anterior and posterior corneal arc lengths along with central cross-sectional areas are statistically different between healthy and keratoconus eyes.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

